SUSQUEHANNA INTERNATIONAL GROUP, LLP - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 70 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$739,176
+31.2%
129,680
+39.0%
0.00%
Q4 2022$563,472
-9.8%
93,290
-1.4%
0.00%
Q3 2022$625,000
-12.0%
94,591
-30.4%
0.00%
Q2 2022$710,000
+157.2%
135,928
+239.8%
0.00%
Q1 2022$276,000
-62.1%
40,000
-31.7%
0.00%
Q4 2021$728,000
+18.8%
58,550
+198.3%
0.00%
Q3 2021$613,000
+24.8%
19,630
+14.4%
0.00%
Q2 2021$491,00017,1530.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$124,994,0001.61%
Baker Brothers Advisors 10,123,824$126,042,0000.61%
Pinz Capital Management, LP 43,800$545,0000.21%
HHLR ADVISORS, LTD. 583,333$7,262,0000.11%
Rock Springs Capital Management LP 368,959$4,594,0000.11%
Nan Fung Group Holdings Ltd 20,350$253,0000.08%
Virtus ETF Advisers LLC 13,815$172,0000.06%
PDT Partners, LLC 35,907$447,0000.03%
Jump Financial, LLC 36,900$459,0000.03%
Parkwood LLC 12,667$158,0000.03%
View complete list of PRELUDE THERAPEUTICS INC shareholders